Catalyst Wire Dossier Catalyst Wire Dossier

Foster 100/6 mg pMDI

· Chiesi Farmaceutici S.p.A.
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Foster 100/6 mg pMDI, covering 2023-11-28 to 2026-08-10. Get the full timeline:

Most recent: Clinical Trial Results: Foster 100/6 mg NEXThaler Versus Foster 100/6mg Pressurized Metered-dose Inhaler (pMDI) in Patients With Controlled Asthma. [Phase 3]

See pricing